2 withdrawn. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Withdrawn 2 |
| Phase 3 | 2 | Withdrawn 2 |
Follow REM Sleep Behavior Disorder: new trials by email Literature Review of REM Sleep Behavior Disorder trials Research Report on REM Sleep Behavior Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease Rasagiline - REM Sleep Behavior Disorder, Parkinson Disease | Phase 2 / Phase 3 | Withdrawn | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2023-01-01 | 2025-01-07 | |
| A Study of Efficacy and Safety of Idebenone Vs. Placebo in Prodromal Parkinson Disease Idebenone, Placebo oral tablet - REM Sleep Behavior Disorder, Parkinson Disease | Phase 2 / Phase 3 | Withdrawn | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2020-01-01 | 2025-01-07 |
Parkinson Disease (2) · Synucleinopathies (1)
Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Mental Disorders (2) · Movement Disorders (2) · Nervous System Diseases (2) · Neurodegenerative Diseases (2) · Parasomnias (2) · Parkinsonian Disorders (2) · REM Sleep Parasomnias (2) · Sleep Wake Disorders (2) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Proteostasis Deficiencies (1) · Synucleinopathies (1)
idebenone (1) · rasagiline (1)
Second Affiliated Hospital, Zhejiang University, School of Medicine (2)
China (1)